Int J Angiol 2019; 28(03): 173-181
DOI: 10.1055/s-0039-1685200
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Management of Buerger's Disease in Endovascular Era

1  Vascular Surgery Department, Faculty of Medicine, Cairo University, Egypt
,
Ahmed G. Karmota
1  Vascular Surgery Department, Faculty of Medicine, Cairo University, Egypt
,
Ahmed M. Abuhadema
1  Vascular Surgery Department, Faculty of Medicine, Cairo University, Egypt
,
Ahmed A. Shaker
1  Vascular Surgery Department, Faculty of Medicine, Cairo University, Egypt
,
Hany M. Abdelmawla
1  Vascular Surgery Department, Faculty of Medicine, Cairo University, Egypt
,
Mahmoud M. Nasser
1  Vascular Surgery Department, Faculty of Medicine, Cairo University, Egypt
,
Hossam Y. Elmahdy
1  Vascular Surgery Department, Faculty of Medicine, Cairo University, Egypt
,
Hesham A. Mostafa
1  Vascular Surgery Department, Faculty of Medicine, Cairo University, Egypt
,
Hussein M. Khairy
1  Vascular Surgery Department, Faculty of Medicine, Cairo University, Egypt
› Author Affiliations
Further Information

Publication History

Publication Date:
19 April 2019 (eFirst)

Abstract

This study was aimed to report data on the feasibility, safety, and effectiveness of endovascular procedures in a thromboangiitis obliterans diagnosed patients presenting with critical limb ischemia (CLI). Prospective study conducted on patients affected by Buerger's disease who presented to our center along 2 years. Clinical, radiological, and patient-based outcomes were recorded at 3, 6, and 12 months after the intervention. Total 39 patients were included in the study. Fifteen (38.5%) patients underwent percutaneous transluminal angioplasty, another 15 patients (38.5%) underwent follow-up on medical treatment, there are four other patients (10.3%) underwent surgical bypass, and five (12.8%) patients underwent lumbar sympathectomy. The 12 months' outcome showed 66.7% technical success in endovascular group with 46.7% patency rate (p-value = 0.06), 86.7% limb salvage rate (LSR; p-value < 0.04), and 66.7% clinical improvement (p-value = 0.005). The endovascular management of Buerger's disease is feasible, save, and effective with high rate of LSR and clinical improvement.